A kind of preparation method of indiplon intermediate

A technology for indiplon and intermediates, which is applied in the field of preparation of indiplon intermediates, can solve the problems of poor cyclization regioselectivity, long reaction time, cumbersome post-processing and the like, achieves easy operation, reduced synthesis cost, The effect of increasing productivity

Active Publication Date: 2022-03-22
XINXIANG MEDICAL UNIV
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

And at present synthetic intermediate 5 is to adopt N-methyl-N-[3-[3-(dimethylamino)-1-ketone-2-propenyl]phenyl]-acetamide 6 and 3-amino-4 -Cyanopyrazole condensation, which has the disadvantages of expensive reagents, poor cyclization regioselectivity, long reaction time, low yield, and cumbersome post-treatment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of preparation method of indiplon intermediate
  • A kind of preparation method of indiplon intermediate
  • A kind of preparation method of indiplon intermediate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] Preparation of compound 3

[0022]

[0023] Add m-nitrobenzaldehyde 1 (75.5mg, 0.5mmol), 3-amino-4-cyanopyrazole 2 (54mg, 0.5mmol), triethylamine (101mg, 1mmol), ammonium iodide in a 35mL sealed tube (72.5mg, 0.5mmol), di-tert-butyl peroxide (219mg, 1.5mmol) and toluene (2mL), then placed in an oil bath at 130°C and stirred for 10h. Add 50mL of water to quench the reaction, extract with ethyl acetate (50mL×3), and then the organic phase is treated with 10% Na 2 S 2 o 3 The solution was washed successively with saturated brine, and dried over anhydrous sodium sulfate. It was filtered, spin-dried, and separated by silica gel column (petroleum ether / ethyl acetate=3 / 1, v / v) to obtain compound 3 (114 mg, 86%) as a yellow solid product. The characterization data of this compound are as follows: 1 H NMR (400MHz, DMSO-d 6 ): δ (ppm) 8.97 (d, J = 1.6Hz, 1H), 8.95 (d, J = 4.8Hz, 1H), 8.88 (s, 1H), 8.48 (dd, J = 8.0, 2.0Hz, 2H) ,7.92(t,J=8.0Hz,1H),7.72(d,J=4.4Hz,1H); 13...

Embodiment 2

[0025] Preparation of Compound 4

[0026]

[0027] Iron powder (184.8 mg, 3.3 mmol) and glacial acetic acid (20 mL) were put into a three-necked flask, stirred, heated to reflux for 10 min, and a solution of compound 3 (265 mg, 1 mmol) in glacial acetic acid (25 mL) was added dropwise. Maintain the reflux state, after the dropwise addition is completed, reflux for 4h. The reaction was quenched by adding 50 mL of water, extracted with ethyl acetate (50 mL×3), and then the organic phase was washed with saturated brine and dried over anhydrous sodium sulfate. Filtered, spin-dried, and dried to give compound 4 (230 mg, 83%) as a white solid. The characterization data of this compound are as follows: 1 H NMR (400MHz, DMSO-d 6 ):δ(ppm)10.25(s,1H),8.89(d,J=4.4Hz,1H),8.86(s,1H),8.32(t,J=1.8Hz,1H),7.85–7.81(m, 1H), 7.70–7.67(m, 1H), 7.54(t, J=8.0Hz, 1H), 7.50(d, J=4.8Hz, 1H), 2.08(s, 3H); 13 C NMR (100MHz, DMSO-d 6 ):δ(ppm)168.7,153.8,151.1,147.5,147.3,139.4,129.9,129.1,124.3,...

Embodiment 3

[0029] Preparation of compound 5

[0030]

[0031] Sodium hydride (58mg, 2.4mmol) and anhydrous DMF (2mL) were put into a three-necked flask filled with nitrogen, stirred in an ice-water bath, a solution of compound 4 (110.8mg, 0.4mmol) in DMF (6mL) was added dropwise, and After the addition was completed, the reaction was carried out for 5 minutes, and methyl iodide (568 mg, 4 mmol) was added dropwise, and stirring was continued for 30 minutes in an ice-water bath. The reaction was quenched by adding 50 mL of water, extracted with ethyl acetate (50 mL×3), and then the organic phase was washed with saturated brine and dried over anhydrous sodium sulfate. Filtration, spin-drying, and drying gave white solid compound 5, the target product indiplon intermediate (103.6 mg, 89%). The characterization data of this compound are as follows: 1 H NMR (400MHz, CDCl 3): δ (ppm) 8.83 (d, J = 4.4Hz, 1H), 8.45 (s, 1H), 8.02–7.95 (m, 2H), 7.70 (t, J = 7.6Hz, 1H), 7.51 (d, J=7.6Hz, 1H),...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a preparation method of a monoindiplon intermediate, belonging to the technical field of medicinal chemistry. The present invention adopts simple and cheap m-nitrobenzaldehyde and triethylamine as raw materials, and constructs the core skeleton of indiplon with high efficiency and high selectivity through a one-pot series reaction without transition metal catalysis, thereby avoiding the generation of isomers, The formation of by-products is reduced, the yield of the target product is increased, and the synthesis cost is reduced; the indiplon intermediate is prepared through simple nitro reduction modification subsequently. In addition, the reaction conditions for preparing the indiplon intermediate are mild, the operation is simple and convenient, and it is suitable for industrial production.

Description

technical field [0001] The invention belongs to the technical field of medicinal chemistry, and in particular relates to a preparation method of an indiplon intermediate. Background technique [0002] Indiplon (indiplon), the chemical name is N-methyl-N-[3-[3-(2-thiopheneacetyl)pyrazolo[1,5-a]pyrimidin-7-yl]phenyl] Acetamide is a novel pyrazolopyrimidine sedative-hypnotics jointly developed by American Neurocrine and Pfizer. In August 2006, the U.S. FDA approved the marketing of indiplon immediate-release dosage form. Indipron, as a third-generation non-benzodiazepine sedative-hypnotics, can be selectively combined with GABA A receptor alpha 1 It is a new structural analogue of zaleplon, which is widely used in clinical practice. Various studies have shown that indiplon absorbs quickly, takes effect quickly, and has a short duration of action. It has no obvious hangover effect, rebound insomnia and withdrawal symptoms. It has significant curative effect and good toleranc...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityPatents(China)
IPC IPC(8): C07D487/04
CPCC07D487/04
Inventor高庆贺杨利敏刘兆敏张涛张积霞李莹莹
OwnerXINXIANG MEDICAL UNIV